🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Want to know what is coming in precision oncology? Join me, Berend Snijder and Diana Azzam to hear about the State of the Art in Functional Precision Medicine Friday afternoon at the AACR. abstractsonline.com/pp8/#!/20272/s… The Society for Functional Precision Medicine AACR

Thrilled to have participated today in an exciting session AACR on the State of the Art in Functional Precision Medicine alongside leading experts Anthony Letai MD PhD & Berend Snijder The Society for Functional Precision Medicine #AACR24 #SFPM #futureisfunctional

Out now Science Magazine: Ben Hale, Berend Snijder & colleagues report that the internal architecture of T cells at the moment they are activated can influence their fate in response to antigen. 🔗science.org/doi/10.1126/sc…

Awesome #TikTorial & paper, happy to have been part of coercing you Ben Hale. 🤩

As an external talk at Alexandrov Team meeting, on Tue 18th at 10:15am CEST, Ben Hale from the Berend Snijder lab will present on their paper just out in Science science.org/doi/10.1126/sc… The talk is open to public and everyone is welcome! 🔓 Link to join: embl-org.zoom.us/j/94431042602?…

Very proud of this massive lab effort and beautiful outcome!

Find out more about the research from the paper's lead author Ben Hale here ⬇️ vm.tiktok.com/ZGeqDGfyV/

Check out this Tweetorial for an easy summary of our recent paper

Looking forward to talking about #StripyTcells and our recent Science Magazine publication with Theodore Alexandrov, his team, and you (if you want)! The talk is public, so feel free to join: embl-org.zoom.us/j/94431042602?… Big thanks to Theodore & co. for the invitation!

Researchers at ETH Zurich have used a drug screening platform they developed to show that an #Antidepressant, currently on the market, kills #Tumour cells in the dreaded #Glioblastoma – at least in the cell-culture dish. brnw.ch/21wMV3Q

I'm thrilled to announce that our latest study, led by the incredible Berend Snijder and Sohyon Lee, has been published in Nature Medicine. It has been an amazing journey and it paves the way for many future explorations nature.com/articles/s4159…

🧵 NEW 📣 Profiling of >100 approved drugs, mostly cancer drugs & other CNS-penetrant drugs incl antidepressants points to Ca2+-driven AP-1/BTG-pathway induction as a #glioblastoma vulnerability. Authors propose drug-repurposing trials + std chemo for #GBM. #OncTwitter #btsm

A single-cell ex vivo screening of repurposable drugs in #glioblastoma coupled with machine learning show that anti-tumour neuroactive drugs converge on the AP1-BTG pathway and identify the antidepressant vortioxetine as a potential therapeutic agent. nature.com/articles/s4159…

We made it into the most read Swiss newspaper 20min :-D nature.com/articles/s4159… 20min.ch/story/zuercher…

Molecular and functional landscape of malignant serous effusions for precision oncology Nature Medicine Berend Snijder Personalized treatment for patients with advanced solid tumors critically depends on the deep characterization of tumor cells from patient biopsies. Here, we

A single-cell ex vivo screening of repurposable drugs in #glioblastoma coupled with machine learning show that anti-tumour neuroactive drugs converge on the AP1-BTG pathway and identify the antidepressant vortioxetine as a potential therapeutic agent. nature.com/articles/s4159…

See you there!